Exclusive

Publication

Byline

Location

US Patent Issued to Spinogenix on Sept. 15 for "Methods of treating spinal cord injury or damage" (California Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,159, issued on Sept. 15, was assigned to Spinogenix Inc. (Los Angeles). "Methods of treating spinal cord injury or damage" was invented by... Read More


US Patent Issued to Genzyme on Sept. 15 for "Methods for treating symptoms and disorders associated with lysosomal storage diseases" (Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,160, issued on Sept. 15, was assigned to Genzyme Corp. (Cambridge, Mass.). "Methods for treating symptoms and disorders associated with ly... Read More


US Patent Issued to Eisai R&D Management on Sept. 15 for "Method of treating breast cancer" (Massachusetts Inventor)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,161, issued on Sept. 15, was assigned to Eisai R&D Management Co. Ltd. (Tokyo). "Method of treating breast cancer" was invented by Antonio... Read More


US Patent Issued to UNIVERSITA' DEGLI STUDI DI PADOVA on Sept. 15 for "SerpinB3 inhibitor piperidinpropionic acid for tumor treatment" (Italian Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,162, issued on Sept. 15, was assigned to UNIVERSITA' DEGLI STUDI DI PADOVA (Padua, Italy). "SerpinB3 inhibitor piperidinpropionic acid for... Read More


US Patent Issued to Fuji Pharma, KinoPharma on Sept. 15 for "Pharmaceutical preparation and method for producing the same" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,163, issued on Sept. 15, was assigned to Fuji Pharma Co. Ltd. (Tokyo) and KinoPharma Inc. (Tokyo). "Pharmaceutical preparation and method ... Read More


US Patent Issued to NeuroPn Therapeutics on Sept. 15 for "Piperidine urea derivatives for cancer therapy" (Monegasque, Monacan, American, Null Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,164, issued on Sept. 15, was assigned to NeuroPn Therapeutics Inc. (Peachtree Corners, Ga.). "Piperidine urea derivatives for cancer thera... Read More


US Patent Issued to ChemoCentryx on Sept. 15 for "Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies" (California Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,166, issued on Sept. 15, was assigned to ChemoCentryx Inc. (Thousand Oaks, Calif.). "Compositions and methods for treating inflammatory bo... Read More


US Patent Issued to Intas Pharmaceuticals on Sept. 15 for "Naltrexone formulation" (Indian Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,167, issued on Sept. 15, was assigned to Intas Pharmaceuticals Ltd. (Ahmedabad, India). "Naltrexone formulation" was invented by Alkeshkum... Read More


US Patent Issued to H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE on Sept. 15 for "Delta opioid receptor antagonists reprogram immunosuppressive microenvironment to boost immunotherapy" (Washington, Florida Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,168, issued on Sept. 15, was assigned to H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (Tampa, Fla.). "Delta opioid receptor ant... Read More


US Patent Issued to Bristol-Myers Squibb on Sept. 15 for "Dosage forms for Tyk2 inhibitors" (British, American Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,169, issued on Sept. 15, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.). "Dosage forms for Tyk2 inhibitors" was invented by Sh... Read More